14/07/2024
📢 We're proud to be featured in the latest CTech by Calcalist release, focusing on BioGenCell LTD's groundbreaking cell therapy technology for microvascular disease: https://lnkd.in/d4ph7FGN
🤝 A huge thank you to our partners, investors, and advisors for your 𝐮𝐧𝐰𝐚𝐯𝐞𝐫𝐢𝐧𝐠 support!
🙏 A special thank you of course to Marius Nacht and his great team Uri Yaron and Shoham , whose $𝟏𝟔𝐌 investment is the wind in the wings of our phase 2 trial.
And Kudos to the BioGenCell LTD team for their dedication and hard work.
From the article: “Our mission is to improve quality of life and not just extend it. The same patient after treatment can after a few months walk, function, and live without pain.” Dr. Yael Porat. This is why we do what we do, and we are fortunate to have so many wonderful people committed to this journey.
If you or someone you know suffers from Critical Limb Threatening Ischemia and is at risk of losing their limb, do not hesitate to contact us: https://lnkd.in/eBa5Dcbp
https://www.calcalistech.com/ctechnews/article/hki11xl2wa
CEO Yael Porat spoke to CTech about the Israeli biotech company’s groundbreaking cell therapy technology for the common and debilitating disease whose primary treatment today is amputation
